Novo Nordisk and Gilead team up to test fatty liver disease treatment
The two pharma firms will run combined clinical trials to treat NASH disease
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
A study, being carried out by the companies to test the effectiveness of lower doses of tanezumab for osteoarthritis, reported…
Cipla’s Yusuf Hamied recieves Honorary Fellowship of the Royal Society, UK
Cipla's chairman among the 51 experts elected as Honorary Fellows by the Royal Society of London for the year 2019
Dr Yusuf…
Aurobindo recalls 88k Lidocaine injections from US
The company recalled them due to the presence of a hair strand
Aurobindo Pharma has initiated recall of 88,600 vials of Lidocaine…
Granules India gets USFDA nod for pain relief drug
The US Food and Drug Administration (USFDA) has approved its abbreviated new drug application (ANDA) for Acetaminophen 650 mg…
The e-Leaflet concept for pharmaceutical products
With the world moving forward towards digitalisation, we can use the e-leaflet in pharmaceutical products, in turn preventing…
India to be one of the world’s ‘fastest growing bio’ hubs in 2019: CPhI
India has over 70 approved biosimilars in the domestic market (more than any other country) and market penetration – which is…
Abbott’s Digene offers scientific solution for hyperacidity
61 per cent of the population in urban India suffers from hyperacidity at some point in time, shows new market research. Abbott’s…
Govt invites initial bids for strategic sale of IMPCL
IMPCL is engaged in manufacture and supply of ‘ayurvedic’ and ‘unani’ medicines and is under the Ministry of AYUSH
The Government…
Building pharma packaging ecosystem
Globally, drug regulators are tightening norms as well as bringing newer regulations to improve quality and accessibility of…